760 filings
Page 29 of 38
8-K
l8jkxu wxnbv7cc
8 Mar 12
Threshold Pharmaceuticals Reports Fourth Quarter and Year end 2011 Financial AND OPERATIONAL Results
12:00am
8-K
ekjha
21 Feb 12
Threshold Pharmaceuticalsannounces Positive Phase 2B Clinical Trial Results of TH-302 In Patients with Pancreatic Cancer
12:00am
8-K
sqxycthc
21 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
b1niop
3 Feb 12
Entry into a Material Definitive Agreement
12:00am
424B5
7uec0zbnq9xbf5pq
20 Jan 12
Prospectus supplement for primary offering
12:00am
8-K
ablspe wc2am0
20 Jan 12
Entry into a Material Definitive Agreement
12:00am
8-K
fqvqgsbo3h
14 Dec 11
Threshold Pharmaceuticals Announces Update to TH-302 Pancreatic Data to Be Presented at the Oppenheimer Healthcare Conference
12:00am
8-K
36wcu
14 Dec 11
Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results In Patients with Advanced Leukemias
12:00am
8-K
md57 c2vhdmtmxsau
28 Oct 11
Other Events
12:00am
8-K
9vdqik469
30 Sep 11
Other Events
12:00am
8-K
wm62vetbzd8rzh10px
27 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
gjf bgbuc34
25 Jul 11
Other Events
12:00am
EFFECT
n4qyoxlvm
7 Jul 11
Notice of effectiveness
12:00am
8-K
igs2xt5q0w6jhh
6 Jul 11
Other Events
12:00am
CORRESP
womv1qwi0fiufaxfb0w
30 Jun 11
Correspondence with SEC
12:00am
8-K
vozu mswedg283uvpab7
29 Jun 11
Other Events
12:00am
CORRESP
dcd9dj0j
28 Jun 11
Correspondence with SEC
12:00am
UPLOAD
8xxn1ec
27 Jun 11
Letter from SEC
12:00am